HomeCompareCRTX vs ADC

CRTX vs ADC: Dividend Comparison 2026

CRTX yields 102.56% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRTX wins by $4.14M in total portfolio value
10 years
CRTX
CRTX
● Live price
102.56%
Share price
$1.95
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.32M
Annual income
$1,481,817.76
Full CRTX calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — CRTX vs ADC

📍 CRTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRTXADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRTX + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRTX pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRTX
Annual income on $10K today (after 15% tax)
$8,717.95/yr
After 10yr DRIP, annual income (after tax)
$1,259,545.10/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, CRTX beats the other by $1,190,867.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRTX + ADC for your $10,000?

CRTX: 50%ADC: 50%
100% ADC50/50100% CRTX
Portfolio after 10yr
$2.25M
Annual income
$781,307.53/yr
Blended yield
34.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

CRTX
Analyst Ratings
1
Buy
4
Hold
3
Sell
Consensus: Hold
Altman Z
-4.0
Piotroski
2/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRTX buys
0
ADC buys
0
No recent congressional trades found for CRTX or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRTXADC
Forward yield102.56%4.13%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$4.32M$178.9K
Annual income after 10y$1,481,817.76$80,797.29
Total dividends collected$3.87M$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: CRTX vs ADC ($10,000, DRIP)

YearCRTX PortfolioCRTX Income/yrADC PortfolioADC Income/yrGap
1← crossover$20,956$10,256.41$10,990$580.36+$10.0KCRTX
2$42,511$20,087.62$12,301$860.26+$30.2KCRTX
3$83,570$38,082.81$14,104$1,298.62+$69.5KCRTX
4$159,386$69,966.82$16,691$2,008.16+$142.7KCRTX
5$295,256$124,712.82$20,580$3,205.09+$274.7KCRTX
6$531,835$215,911.30$26,754$5,330.02+$505.1KCRTX
7$932,535$363,471.12$37,196$9,345.14+$895.3KCRTX
8$1,593,439$595,626.55$56,244$17,523.09+$1.54MCRTX
9$2,656,155$951,175.34$94,286$35,736.21+$2.56MCRTX
10$4,323,904$1,481,817.76$178,949$80,797.29+$4.14MCRTX

CRTX vs ADC: Complete Analysis 2026

CRTXStock

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Full CRTX Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this CRTX vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRTX vs SCHDCRTX vs JEPICRTX vs OCRTX vs KOCRTX vs MAINCRTX vs NNNCRTX vs EPRTCRTX vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.